AI assistant
Sending…
RESMED INC — Director's Dealing 2014
Mar 5, 2014
30071_dirs_2014-03-05_2a96b4b8-d716-4740-b21b-defae2e41c9a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2014-03-03
Reporting Person: Douglas Robert Andrew (President and COO ResMed Inc.)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-03-03 | ResMed Common Stock | M | 7500 | $15.52 | Acquired | 107525.087 | Indirect |
| 2014-02-05 | ResMed Common Stock | S | 7500 | $43.0928 | Disposed | 100025.087 | Indirect |
| 2014-03-03 | ResMed Common Stock | S | 500 | $42.89 | Disposed | 99525.087 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-03-03 | ResMed Common Stock Options | $15.520 | M | 7500 | Disposed | 2015-11-20 | ResMed Common Stock (7500) | Indirect |
Footnotes
F1: The transaction was conducted under a 10b5-1 Plan as defined under the Securities Exchange Act of 1934, as amended.
F2: Represents date options first became exercisable. Options vest 1/4 per year on the anniversary of the grant.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29